The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
Bill Evans, chief marketing officer at Komodo Health, joins Steve Madden live from the floor of the HLTH conference to discuss how the company’s Healthcare Map is serving as a source for patient data.
Charlie Gayer, chief commercial officer for BioCryst Pharmaceuticals, talks about how his company, which recently launched an oral medicine into a crowded category, used analytics to rethink the rare-disease drug launch.
Rao, CEO of the company, joins Marc Iskowitz to talk about the evolution of the direct-to-consumer telemedicine space and Nurx’s expansion beyond its birth control roots.
Steve Williams, chief medical officer of SomaLogic, joined Steve Madden at HLTH, where they discussed the power of proteomics and its potential impact on health.
Dr. Vivian Lee, President Verily Health Platforms and David Holmberg, CEO, Highmark Health, take us on the journey of their shared vision from the HLTH 2021 conference.
Dr. Geeta Nayyar joins Steve Madden live from the floor of the HLTH conference to discuss her passion in healthcare’s hybrid opportunities and the patient’s journey in healthtech’s digital revolution.
Ferring Pharmaceuticals’ Vice President, Operations, Shetal Vyas, joins Steve Madden live from the floor of the HLTH conference to discuss DE+I and women in the workplace.
We explore the growth of digital solutions for the provision of care and the impact they will have on patients, providers and life sciences companies.
The president and co-founder of Women of Color in Pharma gives her take on a new clinical trial diversity initiative, and previews her group’s upcoming conference.
Nace, brand director for Rare Disease Advisor (an MM+M sister brand), joins Marc Iskowitz to discuss trends shaping the awareness and commercialization of rare disease products.
Simeone, VP of marketing at PulsePoint, joins Marc Iskowitz to explain findings from its half-year State of Health Media report.
Caputo, legislative and programs counsel for Washington watchdog group Issue One, talks about “dark money” and ethics in the advertising about Medicare drug-price negotiations.
MM+M’s Larry Dobrow and Marc Iskowitz recap highlights from the MM+M Awards, including interviews with some of the winners.
GSK Consumer Healthcare’s Tamara Rogers, global chief marketing officer, explains how the work of setting the purpose for its brands took on more urgency during the pandemic.
Javier Evelyn, founder of digital allergy management startup Alerje, discusses the lack of capital for Black founders and why structural exclusion is hampering the digital health ecosystem.
Ipsen’s Paul Murasko and Impericus’ Dr. Osama Hashmi share data-based suggestions for the kind of HCP engagement the industry should move toward in the post-pandemic landscape.
Gomola and Anthony discuss their agencies’ efforts to broaden and diversify the pipeline of healthcare marketing talent.
Calcium’s Steven Michaelson talks about the art of drive and commitment — and about conquering adversity along the way.
Joe Miles of Google Cloud explains where the healthcare system made the biggest technological leaps during the pandemic.
Steve Nelson, CEO of DuPage Medical Group, explains why medicine overall is failing to support doctors’ mental health and what his organization is doing to combat burnout among its healthcare workforce.